[Recurrent operations on the adrenal glands].
Repeat adrenalectomy may be required due to ipsilateral recurrence of benign or malignant adrenal tumors after previous total or subtotal adrenalectomy. Even for multivisceral resection in patients with adrenocortical carcinoma, complete resection of local recurrent tumor offers results similar to those of primary resection (5-year survival 40-60%). In contrast, since no benefit on long-term survival has been shown so far by tumor debulking, palliative tumor resection should only be performed individually for control of severe endocrine symptoms. The effect of endoscopic adrenalectomy in patients with large tumors (>5 cm) or suspected malignancy has still not been well examined. Further studies are required. In any case, during open or endoscopic approach, tumor spillage must be avoided to prevent local tumor cell implantation. Following subtotal adrenalectomy, the risk of ipsilateral recurrence correlates with disease, follow-up, localization, size of the adrenal remnant, and, in case of familial pheochromocytoma, probably with genotype.
Brauckhoff
M
M
Klinik für Allgemein-, Viszeral- und Gefässchirurgie, Martin-Luther-Universität Halle-Wittenberg, Halle/Saale. michael.brauckhoff@medizin.uni-halle.de
Dralle
H
H
D019797:3-Iodobenzylguanidine / Q000627:therapeutic use; D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D000315:Adrenalectomy / Q000379:methods*; D018268:Adrenocortical Carcinoma / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D008939:Mitotane / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D015282:Octreotide / Q000627:therapeutic use; D010166:Palliative Care; D009384:Paraneoplastic Endocrine Syndromes / Q000175:diagnosis / Q000401:mortality / Q000601:surgery; D010673:Pheochromocytoma / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D018714:Radiotherapy, Adjuvant; D012086:Reoperation
D018931:Antineoplastic Agents, Hormonal; D019797:3-Iodobenzylguanidine; D008939:Mitotane; D015282:Octreotide
J Endourol. 1999 Mar;13(2):99-104; discussion 104-6
10213103
Arch Surg. 2001 May;136(5):543-9
11343545
Surgery. 2001 Dec;130(6):1072-7
11742341
Ann Thorac Surg. 1996 Jan;61(1):222-4
8561564
World J Surg. 2002 Aug;26(8):1043-7
12045859
Eur J Surg. 1999 May;165(5):431-5
10391158
World J Surg. 1990 May-Jun;14(3):325-9
1973322
World J Surg. 2000 Nov;24(11):1347-52
11038205
World J Surg. 2004 Dec;28(12):1323-9
15517476
World J Surg. 2000 Jan;24(1):108-13
10594213
Surgery. 1992 Dec;112(6):963-70; discussion 970-1
1455321
Eur J Endocrinol. 2004 Jun;150(6):789-92
15191348
Surgery. 2003 Dec;134(6):1020-7; discussion 1027-8
14668736
World J Surg. 2002 Aug;26(8):1005-12
12045858
World J Surg. 1998 Jun;22(6):621-6; discussion 626-7
9597938
N Engl J Med. 1977 Jun 2;296(22):1269-71
859517
Endocr J. 2002 Apr;49(2):227-9
12081243
Surgery. 1995 Dec;118(6):1090-8
7491528
Urology. 1999 Apr;53(4):679-83
10197840
Horm Res. 2002;57(5-6):197-9
12053093
World J Surg. 2001 Jul;25(7):914-26
11572033
Surg Today. 2004;34(3):251-5
14999539
Surgery. 1985 Jan;97(1):16-20
3966225
Surgery. 2000 Dec;128(6):1007-11;discussion 1011-2
11114636
Endocr Rev. 2001 Feb;22(1):75-110
11159817
Ann Surg Oncol. 1999 Dec;6(8):719-26
10622498
Chirurg. 2003 May;74(5):473-7
12748796
World J Surg. 1990 May-Jun;14(3):330-4
2368435
J Clin Endocrinol Metab. 2000 Jan;85(1):5-7
10634355
J Am Coll Surg. 2004 Apr;198(4):525-34; discussion 534-5
15051000
J Pediatr Surg. 1993 Oct;28(10):1248-51; discussion 1251-2
8263682
J Intern Med. 1995 Oct;238(4):363-7
7595173
J Clin Endocrinol Metab. 1989 Nov;69(5):1078-81
2793991
Eur J Surg. 1999 Jun;165(6):535-8
10433135
Surgery. 2003 Dec;134(6):956-62; discussion 962-3
14668728
Surgery. 1996 Dec;120(6):1064-70; discussion 1070-1
8957496
Clin Endocrinol (Oxf). 1997 Jan;46(1):39-44
9059556
World J Surg. 1992 Jul-Aug;16(4):753-8
1413845
Surgery. 2002 Dec;132(6):1008-11; discussion 1012
12490848
J Laparoendosc Adv Surg Tech A. 2004 Aug;14(4):234-5
15345163
J Urol. 1997 Jun;157(6):2239
9146626
J Clin Endocrinol Metab. 2002 Dec;87(12):5367-84
12466322
J Urol. 1999 Feb;161(2):395-8
9915410
J Clin Endocrinol Metab. 2003 Sep;88(9):4083-7
12970267
J Urol. 2000 Jul;164(1):14-7
10840414
Arch Surg. 2002 Jun;137(6):682-8; discussion 688-9
12049539
World J Surg. 1982 Jul;6(4):397-402
7123976
World J Surg. 1984 Aug;8(4):612-21
6148811
Surgery. 1997 Dec;122(6):1068-73; discussion 1073-4
9426421
ANZ J Surg. 2003 Aug;73(8):664-6
12887546
Horm Res. 1999;52(2):97-100
10681640
Eur Urol. 2000 Sep;38(3):344-8
10940711
Minn Med. 1974 Dec;57(12):951-2
4424014
Eur J Endocrinol. 2004 Jul;151(1):15-27
15248818
J Endourol. 2002 Apr;16(3):171-4
12028627
Chirurg. 1989 Apr;60(4):266-71; discussion 271-2
2566455
Arch Surg. 1974 Apr;108(4):450-4
4815920
Front Horm Res. 2004;31:155-62
14674310
Surgery. 1997 Dec;122(6):1212-8
9426440
Br J Surg. 1999 Jan;86(1):94-7
10027369
J Urol. 1998 Aug;160(2):330-4
9679871
Clin Endocrinol (Oxf). 2004 Mar;60(3):273-87
15008991
Surgery. 1983 Dec;94(6):938-40
6648808
Henry Ford Hosp Med J. 1987;35(2-3):127-8
2891644